The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SMMNY | +4.99% | +37.44% | +6.57% | +49% |
| S&P | +14.5% | +93.32% | +14.09% | +145% |
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $6.42B | 10.0% |
| Gross Profit | $2.47B | 10.0% |
| Gross Margin | 38.52% | 0.0% |
| Market Cap | $62.22B | -3.0% |
| Market Cap / Employee | $0.85M | -5.2% |
| Employees | 73.5K | 2.4% |
| Net Income | $630.69M | 24.1% |
| EBITDA | $1.41B | 33.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.79B | 26.5% |
| Accounts Receivable | $7.15B | 11.3% |
| Inventory | 5.2K | 2.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $13.68B | -11.5% |
| Short Term Debt | $4.75B | 81.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 4.63% | 0.6% |
| Return On Invested Capital | 6.50% | -1.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $836.22M | 54.0% |
| Operating Free Cash Flow | $1.05B | 41.4% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 31.89 | 27.60 | 26.73 | 26.19 | -18.15% |
| Price to Book | 3.43 | 2.90 | 2.93 | 3.09 | -3.18% |
| Price to Sales | 2.78 | 2.44 | 2.43 | 2.45 | -9.39% |
| Price to Tangible Book Value | -8.75 | -8.09 | -9.54 | -8.87 | 0.19% |
| Price to Free Cash Flow TTM | 87.78 | 42.74 | 236.16 | 37.05 | -92.32% |
| Enterprise Value to EBITDA | 47.43 | 67.17 | 59.90 | 55.31 | -27.21% |
| Free Cash Flow Yield | 1.1% | 2.3% | 0.4% | 2.7% | 1202.58% |
| Return on Equity | 10.7% | 10.7% | 11.1% | 11.8% | 11.66% |
| Total Debt | $18.09B | $17.21B | $18.21B | $18.43B | 1.98% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
